Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 6 of 1516 for:    alzheimer's

Alzheimer's Prevention Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Banner Health
Information provided by (Responsible Party):
Jessica Langbaum, PhD, Banner Health Identifier:
First received: December 23, 2013
Last updated: January 2, 2014
Last verified: January 2014

The Alzheimer's Prevention Registry ( will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory & thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit

Alzheimer's Disease

Study Type: Observational [Patient Registry]
Target Follow-Up Duration: 16 Years
Official Title: Alzheimer's Prevention Registry

Resource links provided by NLM:

Further study details as provided by Banner Health:

Primary Outcome Measures:
  • Number of individuals enrolled into Alzheimer's prevention studies [ Time Frame: 16 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Number of individuals referred to Alzheimer's prevention research studies / sites [ Time Frame: 16 years ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • Total number enrolled into the Alzheimer's Prevention Registry [ Time Frame: 16 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 250000
Study Start Date: May 2012
Estimated Study Completion Date: January 2030
Estimated Primary Completion Date: January 2030 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Anyone who meets entry criteria is eligible to join the Registry. We anticipate 250,000 individuals within the United States will enroll.


Inclusion Criteria:

  • Must be able to accept the Registry website terms and conditions

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02022943

Contact: Nellie High 602-839-3121

United States, Arizona
Banner Alzheimer's Institute Recruiting
Phoenix, Arizona, United States, 85006
Principal Investigator: Jessica Langbaum, PhD         
Sponsors and Collaborators
Jessica Langbaum, PhD
Principal Investigator: Jessica Langbaum, PhD Banner Alzheimer's Institute
  More Information

Additional Information:
No publications provided

Responsible Party: Jessica Langbaum, PhD, Associate Director, Banner Health Identifier: NCT02022943     History of Changes
Other Study ID Numbers: APR
Study First Received: December 23, 2013
Last Updated: January 2, 2014
Health Authority: United States: N/A

Keywords provided by Banner Health:

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies processed this record on November 25, 2014